Coagulation Conference

August 13-15, 2008

Conference Overview

This 13th Mayo coagulation conference will provide reviews and updates about laboratory and clinical aspects of bleeding and thrombosing disorders. Didactic presentations will be supplemented with panel discussions and case presentations. Adequate time will be allocated for questions. New features for 2008 include: 1) Four Breakfast-with-the-Experts interactive educational sessions (repeated Thursday and Friday mornings); 2) Conference length extended from 2 to 2.5 days, adjourning Friday noon.

Learning Objectives

Upon completion of the conference participants should be able to:

• Describe mechanisms and control of hemostasis
• Assess common disorders of hemostasis that lead to bleeding or thrombosis
• Recognize rarer disorders of hemostasis
• Explain laboratory evaluation of bleeding or thrombosing diatheses
• Interpret screening and more complex tests of hemostasis
• Evaluate antibody-mediated prothrombotic disorders such as heparin-induced thrombocytopenia, thrombotic thrombocytopenic purpura, or lupus anticoagulant and antiphospholipid syndrome
• Discuss prevention or treatment of bleeding and thrombosis
• Summarize principles of oral anticoagulant therapy and monitoring

Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.

Intended Audience

This program is designed for clinicians, pathologists, scientists, and laboratory technologists whose practices include bleeding and thrombosing diseases.

Educational Grants

This course is supported, in part, by educational grants from coagulation-related diagnostics and therapeutics corporations, in accordance with ACCME Standards.

At the time the site was posted , a complete listing of commercial supporters was not available. Appropriate acknowledgment will be given to all supporters at the time of the meeting.